Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Greenstein

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
The Gerontologist|August 1, 1987
Treatment outcome in a group geropsychiatry program for veteransE M Sullivan, J F Coffey, R A Greenstein
Hospital & Community Psychiatry|February 1, 1993
Cocaine use by schizophrenic outpatients who receive depot neuroleptic medicationA M Stone, R A Greenstein, G Gamble, et al.
The American Journal of Drug and Alcohol Abuse|January 1, 1975
Clinical experience with naltrexoneC P O'Brien, R A Greenstein, J Mintz, et al.
Journal of the American Academy of Dermatology|April 1, 1984
Leukocytoclastic vasculitis secondary to trazodone treatmentS C Mann, M M Walker, G G Messenger, et al.
NIDA Research Monograph|April 1, 1983
Predictors of favorable outcome following naltrexone treatmentR A Greenstein, B D Evans, A T McLellan, et al.
Drug and Alcohol Dependence|October 1, 1983
Predictors of favorable outcome following naltrexone treatmentR A Greenstein, B D Evans, A T McLellan, et al.
NIDA Research Monograph|April 1, 1983
Opioid antagonists: do they have a role in treatment programs?C P O'Brien, R A Greenstein, B Evans, et al.
The Journal of Clinical Psychiatry|September 1, 1984
Naltrexone: a clinical perspectiveR A Greenstein, I C Arndt, A T McLellan, et al.
Plos Genetics|May 18, 2022
Local chromatin context regulates the genetic requirements of the heterochromatin spreading reactionR A Greenstein, Henry Ng, Ramon R Barrales, et al.
Genes & Development|December 6, 2019
Set1/COMPASS repels heterochromatin invasion at euchromatic sites by disrupting Suv39/Clr4 activity and nucleosome stabilityR A Greenstein, Ramon R Barrales, Nicholas A Sanchez, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
The Gerontologist|August 1, 1987
Treatment outcome in a group geropsychiatry program for veteransE M Sullivan, J F Coffey, R A Greenstein
Hospital & Community Psychiatry|February 1, 1993
Cocaine use by schizophrenic outpatients who receive depot neuroleptic medicationA M Stone, R A Greenstein, G Gamble, et al.
The American Journal of Drug and Alcohol Abuse|January 1, 1975
Clinical experience with naltrexoneC P O'Brien, R A Greenstein, J Mintz, et al.
Journal of the American Academy of Dermatology|April 1, 1984
Leukocytoclastic vasculitis secondary to trazodone treatmentS C Mann, M M Walker, G G Messenger, et al.
NIDA Research Monograph|April 1, 1983
Predictors of favorable outcome following naltrexone treatmentR A Greenstein, B D Evans, A T McLellan, et al.
Drug and Alcohol Dependence|October 1, 1983
Predictors of favorable outcome following naltrexone treatmentR A Greenstein, B D Evans, A T McLellan, et al.
NIDA Research Monograph|April 1, 1983
Opioid antagonists: do they have a role in treatment programs?C P O'Brien, R A Greenstein, B Evans, et al.
The Journal of Clinical Psychiatry|September 1, 1984
Naltrexone: a clinical perspectiveR A Greenstein, I C Arndt, A T McLellan, et al.
Plos Genetics|May 18, 2022
Local chromatin context regulates the genetic requirements of the heterochromatin spreading reactionR A Greenstein, Henry Ng, Ramon R Barrales, et al.
Genes & Development|December 6, 2019
Set1/COMPASS repels heterochromatin invasion at euchromatic sites by disrupting Suv39/Clr4 activity and nucleosome stabilityR A Greenstein, Ramon R Barrales, Nicholas A Sanchez, et al.
Pageof 3